Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
7.15
-0.06 (-0.83%)
Sep 10, 2025, 4:00 PM - Market closed
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2014 - 2019 |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Bausch + Lomb | 4.79B | Log In | Log In | Log In | Log In | Upgrade |
Bausch + Lomb Growth | 8.81% | Log In | Log In | Log In | Log In | Upgrade |
Salix | 2.33B | Log In | Log In | Log In | Log In | Upgrade |
Salix Growth | 8.47% | Log In | Log In | Log In | Log In | Upgrade |
Diversified Products | 950.00M | Log In | Log In | Log In | Log In | Upgrade |
Diversified Products Growth | -5.15% | Log In | Log In | Log In | Log In | Upgrade |
Ortho Dermatologies | - | Log In | Log In | Log In | Log In | Upgrade |
Ortho Dermatologies Growth | - | Log In | Log In | Log In | Log In | Upgrade |
International Rx | 1.11B | Log In | Log In | Log In | Log In | Upgrade |
International Rx Growth | 0.36% | Log In | Log In | Log In | Log In | Upgrade |
Solta Medical | 440.00M | Log In | Log In | Log In | Log In | Upgrade |
Solta Medical Growth | 30.59% | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2014 - 2019 |
Other | -2.06B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 1.93% | Log In | Log In | Log In | Log In | Upgrade |
Bausch + Lomb Segment Profit | 1.11B | Log In | Log In | Log In | Log In | Upgrade |
Bausch + Lomb Segment Profit Growth | -2.02% | Log In | Log In | Log In | Log In | Upgrade |
Other | -2.06B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 1.93% | Log In | Log In | Log In | Log In | Upgrade |
Salix Segment Profit | 1.60B | Log In | Log In | Log In | Log In | Upgrade |
Salix Segment Profit Growth | 10.81% | Log In | Log In | Log In | Log In | Upgrade |
Diversified Products Segment Profit | 626.00M | Log In | Log In | Log In | Log In | Upgrade |
Diversified Products Segment Profit Growth | -1.45% | Log In | Log In | Log In | Log In | Upgrade |
Ortho Dermatologies Segment Profit | - | Log In | Log In | Log In | Log In | Upgrade |
Ortho Dermatologies Segment Profit Growth | - | Log In | Log In | Log In | Log In | Upgrade |
International Rx Segment Profit | 376.00M | Log In | Log In | Log In | Log In | Upgrade |
International Rx Segment Profit Growth | 0.83% | Log In | Log In | Log In | Log In | Upgrade |
Solta Medical Segment Profit | 213.00M | Log In | Log In | Log In | Log In | Upgrade |
Solta Medical Segment Profit Growth | 39.52% | Log In | Log In | Log In | Log In | Upgrade |